Jonathan Bohlen
Impact in
- Immunology top 5%
- Immunodeficiency and Autoimmune Disorders
- interferon and immune responses
- T-cell and B-cell Immunology
- Infectious Diseases top 5%
- SARS-CoV-2 and COVID-19 Research
- COVID-19 Clinical Research Studies
- Tuberculosis Research and Epidemiology
Papers in
- Immunology 22
- Immunodeficiency and Autoimmune Disorders 17
- T-cell and B-cell Immunology 4
- interferon and immune responses 4
-
- Tuberculosis Research and Epidemiology 4
- COVID-19 Clinical Research Studies 2
- Co-authors
- Aurelio A. Teleman (8 shared papers)Bernd Bukau (2 shared papers)Kai Fenzl (2 shared papers)Günter Krämer (2 shared papers)Ashwin Sriram (1 shared paper)Thomas E. Dever (1 shared paper)Joo-Ran Kim (1 shared paper)Joseph Daniel Puglisi (1 shared paper)
- Journals
- The Journal of Experimental Medicine (5 papers)Cell (5 papers)Journal of Clinical Investigation (3 papers)Nature (3 papers)Science Immunology (2 papers)
- Partner nations
- FranceUnited StatesGermany
In The Last Decade
Jonathan Bohlen
37 papers receiving 1.5k citations
Jonathan Bohlen's Hit Papers
Peers
Comparison fields: 5 of 87
- Immunology 526
- Infectious Diseases 286
- Molecular Biology 456
- General Dentistry 2
- Genetics 127
Countries citing papers authored by Jonathan Bohlen
This map shows the geographic impact of Jonathan Bohlen's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Jonathan Bohlen with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Jonathan Bohlen more than expected).
Fields of papers citing papers by Jonathan Bohlen
This network shows the impact of papers produced by Jonathan Bohlen. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Jonathan Bohlen. The network helps show where Jonathan Bohlen may publish in the future.
Co-authors
The 25 scholars most cited alongside Jonathan Bohlen, linked wherever they have co-authored with each other. Click a name or a connecting line to browse the papers they share.
All Works
Showing the 20 most-cited of 41 papers — load more, or switch the sort, to bring in the rest.
| # | Work | ||
|---|---|---|---|
| 1 | Human genetic and immunological determinants of critical COVID-19 pneumonia Hit paper breakdown → | 2022 | 282 |
| 2 | 2020 | 105 | |
| 3 | 2022 | 92 | |
| 4 | 2023 | 85 | |
| 5 | 2018 | 82 | |
| 6 | 2023 | 80 | |
| 7 | 2023 | 75 | |
| 8 | 2022 | 74 | |
| 9 | 2020 | 70 | |
| 10 | 2022 | 54 | |
| 11 | 2021 | 52 | |
| 12 | 2023 | 50 | |
| 13 | 2024 | 41 | |
| 14 | 2023 | 40 | |
| 15 | 2024 | 38 | |
| 16 | 2022 | 33 | |
| 17 | 2018 | 31 | |
| 18 | 2023 | 31 | |
| 19 | 2016 | 30 | |
| 20 | 2023 | 21 |
About Jonathan Bohlen
Jonathan Bohlen is a scholar working on Immunology, Infectious Diseases, Molecular Biology, Cell Biology and Genetics, having authored 41 papers that have together received 1.5k indexed citations. Recurring topics across this work include Immunodeficiency and Autoimmune Disorders (17 papers), RNA and protein synthesis mechanisms (11 papers), T-cell and B-cell Immunology (4 papers), interferon and immune responses (4 papers), Tuberculosis Research and Epidemiology (4 papers), Microtubule and mitosis dynamics (2 papers), PI3K/AKT/mTOR signaling in cancer (2 papers) and COVID-19 Clinical Research Studies (2 papers). The work is most often cited by research in Immunology (526 citations), Infectious Diseases (286 citations), Molecular Biology (456 citations), General Dentistry (2 citations) and Genetics (127 citations). Jonathan Bohlen has collaborated with scholars based in France, United States and Germany. Frequent co-authors include Aurelio A. Teleman, Bernd Bukau, Kai Fenzl, Günter Krämer, Ashwin Sriram, Thomas E. Dever, Joo-Ran Kim, Joseph Daniel Puglisi, Byung‐Sik Shin and Carlos Alvarado. Their work appears in journals such as The Journal of Experimental Medicine, Cell, Journal of Clinical Investigation, Nature and Science Immunology.
Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.